GSK share price ticks up as cost-cutting talk swirls ahead of Feb. 4 results
GSK shares rose 0.3% to 1,882.5 pence in early London trading ahead of its full-year and Q4 earnings due Feb. 4. The Times reported GSK may pursue cost cuts and changes to European manufacturing. Analysts expect Q4 turnover of £8.5 billion and core EPS of 23 pence. Shares have climbed about 40% since April 2025.